相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alterations in cortical interneurons and cognitive function in schizophrenia
Samuel J. Dienel et al.
NEUROBIOLOGY OF DISEASE (2019)
Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia
Makoto Tsubomoto et al.
CEREBRAL CORTEX (2019)
Sleep spindles and slow waves in schizophrenia and related disorders: main findings, challenges and future perspectives
Anna Castelnovo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2018)
A hypothalamic circuit for the circadian control of aggression
William D. Todd et al.
NATURE NEUROSCIENCE (2018)
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Michael J. Gandal et al.
SCIENCE (2018)
Improved identification of concordant and discordant gene expression signatures using an updated rank-rank hypergeometric overlap approach
Kelly M. Cahill et al.
SCIENTIFIC REPORTS (2018)
Requirement for NF-kappa B in maintenance of molecular and behavioral circadian rhythms in mice
Hee-Kyung Hong et al.
GENES & DEVELOPMENT (2018)
Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm
Leslie Citrome
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Preliminary Study on Quantitative Sleep EEG Characteristics in Patients with Schizophrenia
Seong Min Oh et al.
PSYCHIATRY INVESTIGATION (2017)
Schizophrenia and sleep disorders: links, risks, and management challenges
Rachel E. Kaskie et al.
NATURE AND SCIENCE OF SLEEP (2017)
Effects of aging on circadian patterns of gene expression in the human prefrontal cortex
Cho-Yi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Menachem Fromer et al.
NATURE NEUROSCIENCE (2016)
Altered circadian clock gene expression in patients with schizophrenia
Anne-Sofie Johansson et al.
SCHIZOPHRENIA RESEARCH (2016)
Sundowning'' as a biological phenomenon: current understandings and future directions: an update
Gowrishankar Gnanasekaran
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
David W. Volk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
Veronica Reinhart et al.
NEUROBIOLOGY OF DISEASE (2015)
A circadian gene expression atlas in mammals: Implications for biology and medicine
Ray Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Circadian rhythms in cognitive functioning among patients with schizophrenia: Impact on signal detection in clinical trials of potential pro-cognitive therapies
Michael R. Hufford et al.
SCHIZOPHRENIA RESEARCH (2014)
Circadian patterns of gene expression in the human brain and disruption in major depressive disorder
Jun Z. Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: With application to major depressive disorder
Xingbin Wang et al.
BMC BIOINFORMATICS (2012)
Sleep and circadian rhythm disruption in schizophrenia
Katharina Wulff et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription
Mary L. Spengler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Circadian rhythms and cognition in schizophrenia
Katharina Wulff et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Circadian Clock Gene Expression in Brain Regions of Alzheimer's Disease Patients and Control Subjects
Nicolas Cermakian et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2011)
Rank-rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures
Seema B. Plaisier et al.
NUCLEIC ACIDS RESEARCH (2010)
OLANZAPINE: A REVIEW OF RAPID AND LONG-ACTING PARENTERAL FORMULATIONS
R. T. Owen
DRUGS OF TODAY (2010)
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder
Harvey M. Morris et al.
CEREBRAL CORTEX (2008)
Cell and Receptor Type-Specific Alterations in Markers of GABA Neurotransmission in the Prefrontal Cortex of Subjects with Schizophrenia
David A. Lewis et al.
NEUROTOXICITY RESEARCH (2008)
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
T. Hashimoto et al.
MOLECULAR PSYCHIATRY (2008)
Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation
Brooke H. Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis
K Iwamoto et al.
HUMAN MOLECULAR GENETICS (2005)
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia
T Hashimoto et al.
JOURNAL OF NEUROSCIENCE (2005)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins
CL Beasley et al.
BIOLOGICAL PSYCHIATRY (2002)
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia
FA Middleton et al.
JOURNAL OF NEUROSCIENCE (2002)
Clinical pharmacokinetics of quetiapine - An atypical antipsychotic
CL DeVane et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
